About Asahi Kasei
Asahi Kasei is a company based in Tokyo (Japan) founded in 1931. The company has 50,350 employees as of March 31, 2024. Asahi Kasei has completed 1 acquisition, including AiCuris. Asahi Kasei operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
- Headquarter Tokyo, Japan
- Employees 50350 as on 31 Mar, 2024
- Stage Public
-
Sectors
Chemicals & MaterialsHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Asahi Kasei Corporation
-
Annual Revenue
$19.37 B (USD)9.06as on Mar 31, 2024
-
Net Profit
$860.15 M (USD)208.17as on Mar 31, 2024
-
EBITDA
$2.54 B (USD)23.25as on Mar 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
50350
as on Mar 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Asahi Kasei
Asahi Kasei is a publicly listed company on the TSE with ticker symbol 3407 in Japan, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Asahi Kasei
Unlock access to complete
Unlock access to complete
Funding Insights of Asahi Kasei
Investors in Asahi Kasei
Asahi Kasei has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Asahi Kasei
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Asahi Kasei
Asahi Kasei has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AiCuris.
Investment portfolio details for Asahi Kasei
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Antiviral and antibacterial therapeutics for infectious diseases are developed.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Asahi Kasei
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Asahi Kasei
Detailed financials for Asahi Kasei
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Asahi Kasei Comparisons
Peer comparison for Asahi Kasei
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Asahi Kasei
Asahi Kasei operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Asahi Kasei
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Asahi Kasei
Complete news archive for Asahi Kasei
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asahi Kasei
Asahi Kasei was founded in 1931 and raised its 1st funding round 84 years after it was founded.
Asahi Kasei is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Hideki Kobori is the current CEO of Asahi Kasei.
As of Mar 31, 2024, the latest employee count at Asahi Kasei is 50,350.
Annual revenue of Asahi Kasei is $19.37B as on Mar 31, 2024.
Asahi Kasei was established in 1931 in Tokyo, Japan, and operates as a contract development and manufacturing organization in the pharmaceutical sector. Focus is placed on producing liquid, solid, and injectable drug formulations for clients. Services encompass development and manufacturing processes tailored to pharmaceutical needs. Leadership is provided by President and CEO Hideki Kobori, with headquarters maintained in Tokyo.
Asahi Kasei's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Yes, Asahi Kasei is publicly traded on TSE under the ticker symbol 3407.
Asahi Kasei has made 1 acquisition, including AiCuris.
Asahi Kasei has 1 investor. Key investors include European Union.
The ticker symbol of Asahi Kasei is 3407 on TSE.